Seqens Group Opens Flagship Pharmaceutical R&D Center in Greater Boston
Tuesday, 31 January 2023
NEWBURYPORT, Mass.--(BUSINESS WIRE)-- #CDMO--Seqens Group opened Seqens Boston R&D Center, a state-of-the-art lab in Devens, Mass. to serve as one of the companyβs global centers of excellence.
|
||||
You Might Like |
||||
